Prourocare Medical Inc. - Current report filing (8-K)
September 16 2008 - 5:20PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported)
|
September 10, 2008
|
ProUroCare Medical Inc.
(Exact name of registrant as specified in its charter)
Nevada
|
|
333-103781
|
|
20-1212923
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
|
|
|
|
|
5500 Wayzata Blvd.,
Suite 310, Golden Valley, MN
|
|
55416
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants
telephone number, including area code
|
952-476-9093
|
(Former name or former address, if changed since last
report.)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)
Item 1.01
Entry into Material Definitive Agreements
Amendment of Profile, LLC Promissory Note
On September 10,
2008, ProUroCare Medical Inc. (the Company) amended its $150,000 Promissory
Note with Profile, LLC (Profile), dated April 3, 2008. Under the terms of the amendment, the maturity
date of the promissory note was extended from August 29, 2008 until September 25,
2008. In addition, a 45-day cure period
before
Profile could enforce
its right to have the Assets returned
in the event of default was eliminated.
Amendment of Promissory Notes
On September 12,
2008, the Company amended three promissory notes issued in favor of James
Davis, William Reiling and the Phillips W. Smith Family Trust, each 5%
shareholders of the Company. Under the
terms of the amendments, the maturity date of each $37,500 note was changed
from September 1, 2008 to the earlier of the seven days after the date the
Company closes on an underwritten public offering of equity securities or December 31,
2008. In addition, each note holder was
given the option of converting the principal and interest into shares of the
Companys common stock at price equal to 70% of the price of the securities
sold in that underwritten public offering, in lieu of cash
Item 9.01
Financial Statements and Exhibits
(d) Exhibits
10.1
Amendment
Number 1 to $150,000 Promissory Note Issued by ProUroCare Medical Inc. in favor
of Profile L.L.C., dated April 3, 2008.
10.2
Form of
Amendment Number 1 to $37,500 Promissory Notes dated April 3, 2008.
SIGNATURES
Pursuant to the requirements of the Securities and
Exchange Act of 1934, as amended, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
|
PROUROCARE MEDICAL INC
.
|
|
|
|
|
September 16, 2008
|
By:
|
/s/ Richard C. Carlson
|
|
|
Richard C. Carlson
|
|
|
Chief Executive Officer
|
2
EXHIBIT
INDEX
Exhibit No.
|
|
Description
|
|
|
|
10.1
|
|
Amendment Number 1 to $150,000 Promissory Note
Issued by ProUroCare Medical Inc. in favor of Profile L.L.C., dated
April 3, 2008.
|
|
|
|
10.2
|
|
Form of Amendment Number 1 to $37,500
Promissory Notes dated April 3, 2008.
|
3
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jul 2023 to Jul 2024